Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(a) On January 3, 2022, the Board of Directors of CyberOptics Corporation (the


    Company) increased the size of its Board and appointed Dr. Cordell Hardy to
    its Board of Directors. Dr. Hardy has been employed by 3M Company since
    2003, most recently as Senior Vice President, Corporate R&D Operations. 3M
    Company is a large publicly traded industrial that develops, manufactures,
    and markets various products on a worldwide basis through four business
    segments: Safety and Industrial, Transportation and Electronics, Health
    Care, and Consumer. Dr. Hardy also serves as Treasurer and on the Board of
    Directors of Minnesota Community Care, a federally-qualified health clinic
    operator. Dr. Hardy received a PhD in Chemical Engineering from the
    University of Minnesota, as well as a Bachelor's of Science degree in
    Chemical Engineering from Florida A&M University.

    There is no arrangement or understanding between Dr. Hardy and any other
    person pursuant to which he was appointed as a director. There are no
    transactions in which Dr. Hardy has an interest requiring disclosure under
    Item 404(a) of Regulation S-K.

    The Board is currently in the process of reviewing committee assignments.

    Dr. Hardy will be compensated in accordance with the Company's
    non-management director compensation program, which is described in the
    Company's definitive proxy statement.

(b) On December 28, 2021 and effective as of December 31, 2021, Michael M.

Selzer Jr. informed the Board of Directors of the Company of his decision
    not to stand for re-election as a director at the Company's 2022 Annual
    Meeting of Shareholders. Mr. Selzer will therefore retire from the Board of
    Directors effective upon the expiration of his current term at the 2022
    Annual Meeting. Mr. Selzer's decision to retire is not due to any
    disagreement with the Company on any matter related to its operations,
    policies or practices.


Item 7.01   Regulation FD Disclosure.

(b) A press release issued by the Company on January 3, 2022 announcing the

appointment of Dr. Hardy to the Company's Board of Directors and Mr.

Selzer's decision not to stand for re-election to the Company's Board of

Directors is attached to this Current Report on Form 8-K as Exhibit 99.1.

© Edgar Online, source Glimpses